trial · primary record
Duloxetine
Inflammatory Bowel Diseases
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 32 |
| Primary completion | 2027-10-31 |
| Primary endpoint | Change in IBD-related disability |
| Registry ID | NCT07431606 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:43:16.702Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07431606
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.